Epaud R, Jonard L, Ducou-le-Pointe H, Delestrain C, Fanen P, Guillot L, Flamein F
Service de pédiatrie, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94000 Créteil, France.
Arch Pediatr. 2012 Feb;19(2):212-9. doi: 10.1016/j.arcped.2011.12.004. Epub 2012 Jan 9.
Lung diseases associated with surfactant metabolism disorders represent a significant but heterogeneous group of rare disorders. Intra-alveolar accumulation of protein related to surfactant dysfunction leads to cough, hypoxemia and radiological diffuse infiltration. Inherited deficiency of pulmonary surfactant protein B (SP-B) was initially described in term newborns who develop severe respiratory failure at birth. More recently, mutations in surfactant protein C (SP-C) or in proteins required for surfactant synthesis such as ATP-binding cassette, sub-family A, member 3 (ABCA3) or NK2 homeobox 1 (NKX2-1) were identified in newborns with respiratory distress but also in children with diffuse infiltrative pneumonia. The aim of this review is to describe the clinical presentation of these diseases but also the diagnostic tools and the treatments options available.
与表面活性剂代谢紊乱相关的肺部疾病是一组重要但异质性的罕见疾病。与表面活性剂功能障碍相关的蛋白质在肺泡内积聚导致咳嗽、低氧血症和放射学上的弥漫性浸润。肺表面活性物质蛋白B(SP-B)的遗传性缺乏最初在足月新生儿中被描述,这些新生儿在出生时就出现严重呼吸衰竭。最近,在患有呼吸窘迫的新生儿以及患有弥漫性浸润性肺炎的儿童中,发现了表面活性物质蛋白C(SP-C)或表面活性剂合成所需蛋白质(如ATP结合盒A亚家族成员3,ABCA3)或NK2同源盒1(NKX2-1)的突变。本综述的目的是描述这些疾病的临床表现、诊断工具和可用的治疗选择。